Cargando…

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW

Detalles Bibliográficos
Autor principal:	Plebani, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642735/ https://www.ncbi.nlm.nih.gov/pubmed/33160218 http://dx.doi.org/10.1016/j.ebiom.2020.103087

Ejemplares similares

SARS-CoV-2 vaccines: Lights and shadows
por: Angeli, Fabio, et al.
Publicado: (2021)

SARS-CoV-2 antibodies titration: a reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Lights and shadows of SARS-CoV-2 infection risk assessment in endoscopy
por: Grassia, Roberto, et al.
Publicado: (2020)

COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
por: Barry, Mazin, et al.
Publicado: (2020)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

Waning antibodies to SARS-CoV-2 – Don't panic
por: Meyer, Benjamin
Publicado: (2021)

Genomic surveillance of SARS-CoV-2: A race against time
por: Romano, Camila M, et al.
Publicado: (2021)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
por: Mahla, Ranjeet Singh, et al.
Publicado: (2022)

Using SARS-CoV-2 Antibody Testing in COVID-19 Research
por: Amraotkar, Alok R., et al.
Publicado: (2023)

Efficient SARS-CoV-2 surveillance strategies to prevent deadly outbreaks in vulnerable populations
por: Toth, Damon J. A., et al.
Publicado: (2021)

Finding the Middle Ground with the Clinical Laboratory’s Role in SARS-CoV-2 Genomic Surveillance
por: Graf, Erin H.
Publicado: (2021)

2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance
por: Lu, Guoqing, et al.
Publicado: (2021)

Shadow of a Pandemic: Persistence of Prenatal SARS-CoV-2 Antibodies in Newborn Blood Spots
por: Sciortino, Stanley, et al.
Publicado: (2023)

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
por: Owen, Sophie I., et al.
Publicado: (2022)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
por: Wolfe, Ian D., et al.
Publicado: (2021)

Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

“The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection?
por: Moss, Paul
Publicado: (2020)

Public health actions to control new SARS-CoV-2 variants
por: Grubaugh, Nathan D., et al.
Publicado: (2021)

Omicron variant of SARS-CoV-2 – A new kid on the block
por: Husain, Uneza, et al.
Publicado: (2022)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Syndromic Surveillance System for MERS-CoV as New Early Warning and Identification Approach
por: Salamatbakhsh, Maryam, et al.
Publicado: (2020)

A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Antibody responses in mild COVID-19 hospital staff
por: Plebani, Mario
Publicado: (2020)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

SARS CoV-2 load in periodontal disease
por: Sahni, Vaibhav
Publicado: (2022)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

Mitigating airborne transmission of SARS-CoV-2
por: Addleman, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mncbin2dph83bepedh987qv12k